Faruqi & Faruqi, LLP Launches An Investigation Against McKesson Corporation (MCK) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK) for potential breaches of fiduciary duties in connection with their conduct in seeking shareholders’ approval for the 2013 Stock Plan.

Specifically, in the Proxy Statement filed by the Company with the Securities and Exchange Commission on June 21, 2013, the Board of Directors recommends that McKesson’s shareholders vote to approve the 2013 Stock Plan, including the reservation of 30,000,000 shares of common stock for issuance thereunder. The issuance of the additional shares could have a substantial dilutive effect on the shares of McKesson common stock.

Request more information now by clicking here: www.faruqilaw.com/MCK . There is no cost or obligation to you.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients.

If you own common stock in McKesson and wish to obtain additional information and protect your investments free of charge, please visit us at www.faruqilaw.com/MCK or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330.

Attorney Advertising. (C) 2013 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.

Copyright Business Wire 2010

If you liked this article you might like

House Committee: 2 Pharmacy Managers Sent 12.3 Million Opioid Doses to 1 Store

House Committee: 2 Pharmacy Managers Sent 12.3 Million Opioid Doses to 1 Store

Who Says There Are No Second Chances?

Who Says There Are No Second Chances?

Medical Supply Stocks Get Hit in Latest Example of the 'Amazon Effect'

Medical Supply Stocks Get Hit in Latest Example of the 'Amazon Effect'

Purdue Pharma to Downplay Opioids, Dump 50% of Sales Staff

Purdue Pharma to Downplay Opioids, Dump 50% of Sales Staff

Drug Supply Chain Stocks Dip After White House Recommendations on Drug Pricing

Drug Supply Chain Stocks Dip After White House Recommendations on Drug Pricing